As an appraisal for the application of a new starter culture, more than 200 lactic acid bacteria strains were isolated from raw milk and healthy human feces. The strains showing excellent growth and acid production ability in 10% skim milk media were selected and identified as Lactobacillus casei based on the results of their API carbohydrate fermentation patterns, as well as 16S rDNA sequence analysis. To assess the effect of L. casei strains on irritable bowel disease (IBD), the inhibitory effect of the selected strains against the nitric oxide (NO) production of lipopolysaccharide (LPS)-stimulated RAW 264.7 cells was measured. Among the tested L. casei strains, L. casei MCL was observed to have the greatest NO inhibitory activity. Additionally, L. casei MCL was found to inhibit mRNA expression of pro-inflammatory cytokines (interleukin-1β, IL-6, TNF-α), as well as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) involved in pathophysiologic processes such as inflammation. The mRNA expression of anti-inflammatory cytokines, including IL-10 and transforming growth factor-β (TGF-β) of L. casei MCL, was confirmed using quantitative real-time PCR. In conclusion, L. casei MCL showed decreases in the expression of pro-inflammatory cytokines and up-regulated expression of the anti-inflammatory cytokine.
Introduction
As it is a well-established fact that many gastrointestinal disorders are associated with changes in the intestinal mucosal function and the stability of the intestinal microflora by probiotics, it would be interesting to determine whether fermented milk products containing probiotics could serve as a new functional food to confer health care benefits. Probiotics can be defined as "live microbial food ingredients that, when administered in adequate amounts, confer a health benefit on a host" (FAO/WHO, 2001). Since lactic acid-producing bacteria confer various advantageous effects by improving the ecosystem in the gut, they are referred to as probiotics.
Lactic acid bacteria are widely used as probiotic microorganisms because of the health and nutritional benefits contributed to the host, such as maintaining the balance of the intestinal microflora, lowering of serum cholesterol, and enhancement of immunopotentiating activity and γ-aminobutyric acid (GABA) production (Fuller, 1993; Gilliland and Walker, 1990; Sanders, 1993 ). In addition, a variety of convincing evidence regarding the anti-inflammatory properties of probiotics has been proposed by many studies (Lee et al., 2008; Menard et al., 2004) . Among the probiotics, L. casei strains may be isolated from raw or fermented dairy products, gastrointestinal tracts, and the reproductive systems of humans and animals, as well as fermented plant products (Kandler and Weiss, 1986 ). The L. casei YIT 9029 strain is a typical common probiotic, the immune modulation activities of which have been studied extensively ( Inflammation occurs when the host's immune system attempts to counteract injurious agents such as invading pathogens (Henderson et al., 1996; Ulevitch and Tobias, 1995 (Hanauer, 2002; Macdonald and Monteleone, 2005) . Therefore, the NO inhibitory ability and cytokine profile of L. casei strains were assessed in this study in order to determine the immunomodulating potential of L. casei strains.
Materials and methods
Identification of L. casei MCL The bacterial 16S rRNA gene was amplified by PCR using the HotStarTaq ® Plus Master Mix Kit (Qiagen, USA)
containing DNA polymerase, dNTPs, Tris-HCl (pH 9.0), KCl, MgCl 2 , and primers pBact27F (5'-AGAGTTTGA-TCMTGGCTCAG-3') and pUniv 1492R (5'-GGYTAC-CTTGTTACG ACTT-3') (Lane, 1991) . The PCR product was purified using a PCR purification kit (Qiagen, USA). Gene cloning, DNA transformations using E. coli, DNA manipulations, and agarose gel electrophoresis were performed as reported by Sambrook et al. (1989 
com).
Culture characteristics in skim milk L. casei MCL isolated from raw milk and L. casei YIT 9029 obtained from Korea Yakult Co. were tested for their viable cell count, pH, and acidimetry. To measure the viable cell count, cells were cultured in MRS broth twice and inoculated in 10% skim milk supplemented with 2% glucose. Cells were counted at an interval of 4 h for a total of 36 h. Cultured cells were diluted in anaerobic dilution solution and applied to MRS agar. The plates were cultured in an incubator for 48 h at 37 o C. The pH was tested using a pH meter (M530P, Nova Analytics Corp., USA).
Preparation of bacterial components for nitric oxide assay LAB were cultured in MRS broth at 37 o C for 12 h and harvested by centrifugation at 10,000 g for 15 min. After bacterial cells were washed twice with 1×PBS buffer, samples were heated at 100 o C for 10 min and centrifuged at 10,000 g for 30 min and the supernatant was used for the NO assay after filtration.
The strains grown in skim milk medium at 37 o C for 24 h and were heated at 100 o C for 10 min and centrifuged at 10,000 g for 30 min.
Cell culture RAW 264.7 cells obtained from the Korean Cell Line Bank (Seoul, Korea) were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS) and 1% 100 U/mg penicillin/streptomycin. All cultures were incubated at 37 o C in a humidified atmosphere with 5% CO 2 . The cell number and viability were assessed by Trypan blue dye exclusion on a Neubauer hemocytometer. Cells were cultured to confluence in sterile tissue culture dishes and gently detached by repeated pipetting. For the experiments, cells were cultured in triplicate at a density of 5×10 5 in 24-well tissue culture plates (Nunc, Denmark). Cell cultures were incubated for 24 h and analyzed for NO concentration.
Nitric oxide assay
To assess the NO production-inhibitory activity of L. casei MCL, the RAW 264.7 cells (1×10 6 /mL) previously cultured in DMEM were stimulated for 24 h using LPS (50 ng/mL) and 10% of LAB fractions (the supernatant of bacterial cell suspension or skim milk culture). The concentration of NO was determined by measuring the amount of nitrite in the cell culture supernatant using Griess reagent (Sigma, USA) according to the manufacturer's protocol. The cultured RAW 264.7 cells were briefly centrifuged at 1,000 g for 10 min, with 150 µL of the cell culture supernatant mixed with 150 µL of Griess reagent and subsequently incubated for 10 min at room temperature. The absorbance was measured using a microplate reader at 540 nm and compared to a calibration curve generated using sodium nitrite as a standard.
Preparation of cDNA and real-time PCR Total RNA was collected from stimulated RAW 264.7 cells using TRIzol reagent (Invitrogen, USA), as described by the manufacturer's protocol. RNA was further isolated using the RNeasy Mini Kit from Qiagen (USA), in accordance with the manufacturer's protocol. The remaining DNA in the extract solution was removed with the DNase I kit (Ambion, USA), and cDNA was synthesized using SuperScript III (Invitrogen, USA). The concentration of cDNA was measured using a NanoDrop spectrophotometer (Thermo Scientific, USA) and adjusted to 100 ng/µL.
The expression of selected cytokines in RAW 264.7 cells exposed to L. casei MCL cellular components and skim milk cultures was determined by real-time quantitative PCR using SYBR Green technology with the ABI 7900HT (Applied Biosystems, USA). Primers used for the PCR included glyceraldehydes-3-phosphate dehydrogenase (GAPDH), COX-2, iNOS, TNF-α, IL-1β, IL-6, IL-10, and TGF-β, and the cDNA sequences were obtained from GenBank with accession numbers XM_124295.1, NM_000963, NM_010927, XM_123058.1, NM_008361.3, NM_031168.1, NM_010548.2, NM_011577.1, respectively. The nucleotide sequences of the primers and probes are shown in Table 1 .
Statistical analysis
All samples were measured in triplicate. Statistical analyses were performed using SPSS 18.0 (SPSS for windows, USA). The results of cytokine expression are analyzed by one way ANOVA followed by Turkey's multiple comparisons test. All samples were considered statistically significant at p<0.05.
Result and Discussion
Identification and DNA sequencing of L. casei MCL The strain MCL isolated from raw milk was a catalase negative, non-motile, gram-positive, rod-shaped bacterium. Most of these features are characteristic of the genus Lactobacillus. Biochemical and molecular biological identification were attempted. Carbohydrate fermenta- 
tion patterns showed that this strain was identified as L. paracasei (99.9%) according to the API database. In addition, the 16S rDNA gene sequence of L. casei MCL was deposited into GenBank under the accession number of JN974882. Identification of L. casei at the strain level is crucial for a variety of industrial applications, as it facilitates the tracking of specific strains with industrially-relevant properties. The L. casei MCL isolated from raw milk and L. casei YIT 9029 were tested for their carbohydrate fermentation patterns using the API 50 CHL kit. The results showed that the two strains used carbohydrates such as ribose, galactose, D-glucose, D-fructose, D-mannose, mannitol, sorbitol, N-acetyl glucosamine, esculin, salicin, D-cellobiose, maltose, lactose, saccharose, trehalose, D-turanose, gentiobiose, D-tagatose and gluconate (Table 2) . D-adonitol, L-sorbose, amygdalin, and arbutin were only fermented by L. casei YIT 9029, and inulin and D-melezitose were only fermented by L. casei MCL.
Culture characteristics of L. casei MCL in skim milk
Recently, L. casei strains have been widely used as a starter culture for yogurt and other fermented milk products in the dairy industry. To use LAB as a starter culture, the viable count should be above 6 Log CFU/g in order to supply a sufficient dairy dose (Samona and Robinson, 1991) . Additionally, the pH should be between 4.2 and 4.4 in order to produce the organoleptic qualities of sourness and for the firm coagulum to be satisfactory (Narvhus, 1996) . Among the 204 strains isolated from healthy adult feces and raw milk, only six strains were selected based on their consecutive culturability in 10% skim milk. Finally, L. casei MCL isolated from raw milk was assessed for viable cell count, pH, and titratable acidity. As shown in Fig. 1 , the pH change of L. casei MCL was slightly higher than L. casei YIT 9029. After 16 h, the pH of L. casei YIT 9029 rapidly decreased, while the final pH for L. casei MCL was found to be similar to that of L. casei YIT 9029 (Fig. 1) . The viable cell count was 9 Log CFU/g for both L. casei YIT 9029 and L. casei MCL. Based on these results, L. casei MCL was determined to have potential as a starter culture.
Effect of L. casei MCL on nitric oxide production NO is a suspected mediator in the development of diseases that are associated with chronic inflammation, including cancer. Practically every cell and many immu- casei strains expressed relative rate (%) compared with NO concentration of positive control. The positive control is only treated to LPS and the negative control is only treated to 1X PBS buffer in RAW264.7. As shown in Fig.  2 , the rate of NO inhibition by L. casei MCL was significantly higher than that by the L. casei YIT 9029 strain. Moreover, L. casei MCL exhibited the highest inhibitory rate (%) among the other L. casei strains (Fig. 2b) . The positive control (LPS-treatment sample) produced 21.91 µM NO and L. casei MCL produced 13.02 µM NO (Fig.  2a) . Therefore, we infer that L. casei MCL may exert an anti-inflammatory effect by inhibiting NO production.
Anti-inflammatory effect of cell components obtained from L. casei MCL The mRNA expression of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) and enzymes involved in NO production (iNOS and COX-2) were determined using quantitative real-time PCR. iNOS is a key factor in the production of NO in macrophages stimulated by bacterial endotoxin (LPS), which in turn participates in the inflammatory response with pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 (Nathan and Xie, 1994). IL-6 is a potent mitogenic polypeptide and stimulates cell proliferation in a various types of cells (Stein and Sutherland, 1998) . Therefore, pro-inflammatory cytokines are important indicators of inflammation. According to Morotomi et al. (1996) , the L. casi YIT 9029 strain has been demonstrated potential, when administered dietarily, to prevent cancer through its immunostimulating activity on experimentally-implanted tumors. Similarly, our results have also shown that L. casi YIT 9029 increases the expression of COX-2, iNOS, and IL-1β (data not shown). On the other hand, L. casei MCL was found to suppress all proinflammatory genes (Fig. 3) . This indicates that L. casei MCL has the potential to enhance anti-inflammatory responses. All experiments were conducted in triplicate. Following stimulation with LPS for 24 h, lower levels of pro-inflammatory cytokines were observed in RAW 264.7 cells from the L. casei MCL and LPS-treated sample compared with the sample treated with LPS only.
Stimulation with lipopolysaccharides causes an increase in the secretion of anti-inflammatory IL-10, which may respond to the local effects of inflammation (Yeganegi et Anti-inflammatory effect of fermented milk from L. casei MCL To confirm the immune effects of milk fermented with the L. casei MCL strain, the strain was cultured in 10% skim milk supplemented with 2% glucose for 24 h. The fermented milk containing L. casei MCL tended to reduce the secretion of particular pro-inflammatory cytokines such as COX-2, IL-6, and TNF-α in RAW 264.7 cells (p<0.05) (Fig. 5) and TGF-β to levels similar to those observed in the control sample (p<0.05) (Fig. 6) . How- ever, contrary to the bacterial component, milk fermented with the L. casei MCL was only able to repress the expression of COX-2, TNF-α, IL-6 (p<0.05), and TGF-β to levels similar to those observed in the control sample (p<0.05). These results suggest that milk fermented by L. casei MCL may influence both specific and nonspecific immune responses. Lactobacillus rhamnosus GG downregulates the inflammatory response after milk consumption in milk-hypersensitive adults (Majamaa and Isolauri, 1997) . Thus, the fermented milk from L. casei MCL may reduce the inflammatory response by decreasing the secretion of pro-inflammatory cytokines. It may also have the potential for application in immunomodulating fermented milk. Future studies are required to confirm the immunomodulating activity of L. casei MCL in vivo.
Conclusions
We investigated the effect of immunomodulating of L. casei strains on NO and cytokine expression in several experiments. This study confirms that when the macrophages were infected with LPS, L. casei MCL inhibited production of NO and proinflammatory cytokines. It is probably assume that L. casei MCL had immune regulation activity in macrophage. Inhibiting the substances related with inflammation reaction might show beneficial effect about gastrointestinal tract.
To get more insight into immunomodulating effect by probiotics, future studies combining cytokine gene expression and protein assay in disease models would be useful.
